<- Go Home
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Market Cap
$3.1B
Volume
7.2M
Cash and Equivalents
$2.4M
EBITDA
-$7.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$69.00
52 Week Low
$4.51
Dividend
N/A
Price / Book Value
2.5K
Price / Earnings
-433.56
Price / Tangible Book Value
2.5K
Enterprise Value
$3.1B
Enterprise Value / EBITDA
-453.63
Operating Income
-$7.1M
Return on Equity
177.66%
Return on Assets
-84.97
Cash and Short Term Investments
$2.4M
Debt
$386.3K
Equity
$1.2M
Revenue
N/A
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A